Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Gene Solutions Strengthens China Footprint with Strategic Partnerships in Precision Oncology

Saturday, June 21, 2025

Gene Solutions announces the signing of two strategic Memoranda of Understanding MOUs with ZaoDx and Xiongan MagicBiotech Co Ltd These partnerships mark a focused expansion of Gene Solutions precision

Immuno Cure and PharmaJet Announce Collaboration to Advance a Novel HIV Therapeutic DNA Vaccine Using Needle-Free Technology in Humans

Friday, June 20, 2025

Immuno Cure BioTecha clinicalstage biotechnology group based in Hong Kong Science Park is pleased to announce its upcoming collaboration with PharmaJet to evaluate the safety and immunogenicity of HIV therapeutic DNA vaccine

Zemcelpro® (UM171 Cell Therapy) receives positive CHMP opinion for treatment of blood cancer patients without access to suitable donor cells

Friday, June 20, 2025

ExCellThera Inc a world leader in blood stem cell expansion and metabolic fitness announced today the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has adopted a positive opinion recommending granting condit...

ADVANZ PHARMA acquires Testoviron® rights from Bayer in Europe and parts of LATAM, MEA, and APAC

Thursday, June 19, 2025

ADVANZ PHARMA Holdco Limited a UK headquartered global pharmaceutical company with a strategic focus on specialty hospital and rare disease medicines across Europe Canada and Australia has completed the purchase of the commercial rights to Testoviron...

Avata Biosciences and Oceanus Bio Agree to Co-Develop Oral Cannabidiol Therapies for Epilepsy and Schizophrenia in Japan and Asia (Excluding China and India)

Thursday, June 19, 2025

Avata Biosciences Holdings Ltd Avata a pioneering biopharmaceutical company specializing in neuroscience drug discovery and clinical development today announced it has signed a codevelopment and licensing agreement with Oceanus Bio

NEC and Chugai Pharmaceutical use AI to potentially enhance cancer treatment

Thursday, June 19, 2025

NEC Corporation in collaboration with Chugai Pharmaceutical Co Ltd has conducted an experiment using AI to predict drug combinations that can possibly enhance the effectiveness of certain cancer treatments

Sartorius expands manufacturing and R&D capacities for innovative bioprocess solutions in France

Thursday, June 19, 2025

The life science group Sartorius today celebrates the completion of a multiyear capacity expansion project at the headquarters of its French subgroup Sartorius Stedim Biotech in Aubagne The investments highlight Sartorius commitment to providing cust...

LOTTE BIOLOGICS Signs Antibody Manufacturing Contract with Ottimo Pharma

Thursday, June 19, 2025

Korea LOTTE BIOLOGICS announced on June that it has signed a contract manufacturing agreement for antibody therapeutics with Ottimo Pharma a biopharmaceutical company developing firstinclass

FDA Grants Orphan Drug Designation to Medicovestor’s First-in-Class ADC for Pancreatic Cancer

Wednesday, June 18, 2025

Medicovestor Inc a biotechnology company advancing nextgeneration antibodydrug conjugates ADCs announced today that the US Food and Drug Administration FDA has granted Orphan Drug Designation ODD to ADoBind MC its lead candidate for the treatment of...

LOTTE BIOLOGICS Signs Tripartite MOU

Wednesday, June 18, 2025

LOTTE BIOLOGICS President James Park Axcelead Drug Discovery Partners IncRepresentative Director and CEO Kengo Okada PhD and Kanaph Therapeutics IncCEO Byoung Chul Lee PhD